2024;16(4): e57856
Severe Disease & Prevention Targeting postprandial glucose spikes is associated with reduced atherogenic stress and may slow progression of microvascular complications (retinopathy, neuropathy) and macrovascular disease , lowering long-term cardiovascular risk
Indian J Cardiovasc Dis Women WINCARS
With healthcare providers prioritizing effective and long-term solutions for metabolic diseases, GLP-1 therapies have gained widespread acceptance
In an email, Genna Hymowitz, director of metabolic and bariatric psychology and a clinical associate professor at Stony Brook Medicine, said more research was needed "before we prescribe GLP-1s to people who are not overweight, and we need to better understand the long-term risks of GLP-1s
When you cycle back on, your sensitivity to the peptides is diminished, and then you get the most impact from the money spent